Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis

被引：0
|
作者：
Cook, S. [1 ]
Giovannoni, G. [2 ]
Leist, T. [3 ]
Syed, S. [4 ]
Nolting, A. [5 ]
Schick, R. [5 ]
机构：
[1] Rutgers State Univ, New Jersey Med Sch, Newark, NJ USA
[2] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England
[3] Thomas Jefferson Univ, Jefferson Med Coll, Div Clin Neuroimmunol, Philadelphia, PA 19107 USA
[4] EMD Serono Inc, Billerica, MA USA
[5] Merck KGaA, Darmstadt, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P875
引用
收藏
页码：465 / 466
页数：2
相关论文
共 50 条
  • [1] Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis
    Cook, Stuart D.
    Giovannoni, Gavin
    Leist, Thomas P.
    Syed, Sana
    Nolting, Axel
    Damian, Doris
    Schick, Regina
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 54 - 55
  • [2] Updated safety analysis of cladribine tablets in the treatment of patients with multiple sclerosis
    Cook, Stuart
    Giovannoni, Gavin
    Leist, Thomas
    Syed, Sana
    Nolting, Axel
    Damian, Doris
    Schick, Regina
    NEUROLOGY, 2019, 92 (15)
  • [3] Updated Safety Analysis of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis
    Cook, S.
    Giovannoni, G.
    Leist, T.
    King, J.
    Syed, S.
    Nolting, A.
    Schick, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (03) : 469 - 469
  • [4] Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysis
    Cook, Stuart
    Leist, Thomas
    Comi, Giancarlo
    Montalban, Xavier
    Giovannoni, Gavin
    Nolting, Axel
    Hicking, Christine
    Galazka, Andrew
    Sylvester, Elke
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 29 : 157 - 167
  • [5] Updated Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: Integrated Safety Analysis and Post-Approval Data
    Cook, S.
    Giovannoni, G.
    Leist, T.
    Comi, G.
    Syed, S.
    Nolting, A.
    Damian, D.
    Schick, R.
    Jack, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP65 - NP66
  • [6] Updated Safety Of Cladribine Tablets In The Treatment Of Patients With Multiple Sclerosis: Integrated Safety Analysis And Post-approval Data
    Cook, S.
    Giovannoni, G.
    Leist, T. P.
    Comi, G.
    Syed, S.
    Nolting, A.
    Damian, D.
    Schick, R.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 52 - 52
  • [7] Updated safety of cladribine tablets in the treatment of patients with multiple sclerosis: Integrated safety analysis and post-approval data
    Cook, S.
    Giovannoni, G.
    Leist, T.
    Comi, G.
    Syed, S.
    Nolting, A.
    Damian, D.
    Schick, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 767 - 768
  • [8] Updated Safety of Cladribine Tablets in the Treatment of Patients with Multiple Sclerosis: Integrated Safety Analysis and Post-Approval Data
    Cook, S.
    Giovannoni, G.
    Leist, T.
    Comi, G.
    Syed, S.
    Noltine, A.
    Damian, D.
    Schick, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 327 - 328
  • [9] Updated safety of cladribine tablets in the treatment of patients with multiple sclerosis: Integrated safety analysis and post-approval data
    Cook, Stuart
    Giovannoni, Gavin
    Leist, Thomas
    Comi, Giancarlo
    Syed, Sana
    Nolting, Axel
    Damian, Doris
    Schick, Regina
    NEUROLOGY, 2020, 94 (15)
  • [10] Cladribine tablets in the treatment of patients with multiple sclerosis: an integrated analysis of safety from the multiple sclerosis clinical development program
    Cook, S.
    Leist, T.
    Comi, G.
    Montalban, X.
    Sylvester, E.
    Hicking, C.
    Dangond, F.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 305 - 306
12345